High spatiotemporal resolution dynamic contrast-enhanced MRI improves the image-based discrimination of histopathology risk groups of peripheral zone prostate cancer: a supervised machine learning approach.

objectiveTo assess if adding perfusion information from dynamic contrast-enhanced (DCE MRI) acquisition schemes with high spatiotemporal resolution to T2w/DWI sequences as input features for a gradient boosting machine (GBM) machine learning (ML) classifier could better classify prostate cancer (PCa) risk groups than T2w/DWI sequences alone. MATERIALS AND

methodsOne hundred ninety patients (68 ± 9 years) were retrospectively evaluated at 3T MRI for clinical suspicion of PCa. Included were 201 peripheral zone (PZ) PCa lesions. Histopathological confirmation on fusion biopsy was matched with normal prostate parenchyma contralaterally. Biopsy results were grouped into benign tissue and low-, intermediate-, and high-risk groups (Gleason sum score 6, 7, and > 7, respectively). DCE MRI was performed using golden-angle radial sparse MRI. Perfusion maps (K

resultsFor the classification of benign vs. malignant and intermediate- vs. high-grade PCa, perfusion information added relevant information (AUC values 1 vs. 0.953 and 0.909 vs. 0.700, p < 0.001 and p = 0.038), while no statistically significant effect was found for low- vs. intermediate- and high-grade PCa.

conclusionPerfusion information from DCE MRI acquisition schemes with high spatiotemporal resolution to ML classifiers enables a superior risk stratification between benign and malignant and intermediate- and high-risk PCa in the PZ compared with classifiers based on T2w/DWI information alone. KEY POINTS: • In the recent guidelines, the role of DCE MRI has changed from a mandatory to recommended sequence. • DCE MRI acquisition schemes with high spatiotemporal resolution (e.g., GRASP) have been shown to improve the diagnostic performance compared with conventional DCE MRI sequences. • Using perfusion information acquired with GRASP in combination with ML classifiers significantly improved the prediction of benign vs. malignant and intermediate- vs. high-grade peripheral zone prostate cancer compared with non-contrast sequences.